It’s now 2020! How strange does that sound? 2019 was a busy and impactful year at CBCN. So, we thought we’d look back and see what blogs you, our readers, found to be the most valuable. Here’s the top 10 list of most read blogs on CBCN’s Our Voices.
Over the last few years CBCN has been working to educate patients, physicians and the broader cancer advocacy community about biosimilar therapies. From our curated digital magazine on biosimilars to our recently released white paper Breast Cancer & Biosimilars: Recommendations on Use, Implementation and Patient Communications-CBCN is committed to raising awareness about the use of biosimilar therapies for treating breast cancer.
It’s that time of year again! Yesterday you took advantage of all the amazing Cyber Monday deals, gearing up for the holidays and enjoying this festive season with the ones you love. It’s also the time of year where many people start to think about giving to others in need. Since today is Giving Tuesday, we wanted to give you a glimpse into the resources your donations to CBCN help support.
Did you know that accessing treatments for stage IV metastatic breast cancer (mBC) is not universal across Canada? We live in a country that promotes universal health care to all but accessing cancer treatment varies by each province.
Timely access to medications is a key concern for any breast cancer patient, but drug access in Canada has long been a minefield to navigate. Inequitable access to medications across provinces, drug shortages and long wait times to access new treatments are just some of the issues patients and their families routinely encounter in their quest for treatment. National Pharmacare-a plan to reimburse prescription medications in a similar fashion as our healthcare system-has often been proposed as a solution to many of the drug access issues that Canadians currently experience. While Pharmacare has been debated nationally for a long time, it is only recently that the idea has gained real traction and momentum.
Self-care during treatment is so important for maintaining not only a good quality of life but your sanity as well. From doctors appointments, to managing the emotional aspects of a breast cancer diagnosis, there’s a lot to juggle. We’re excited to announce our new partnership with Self Care Catalysts and our Health Storylines mobile app.
On June 12th, the Advisory Council on the Implementation of National Pharmacare released their final report looking at the implementation of a national program to address the inequities that Canadians currently face when it comes to drug access. It outlines 60 recommendations, steps to implementation and key details on things like co-pay, budget costs, strategy for rare diseases, and impacts on patients and providers. Below, we’ve summarized these key details for you to better understand how this new plan for pharmacare would impact you and your family.
We talked a lot on this blog last year about biosimilars; what they are and why it’s important to know about them. With the entry of biosimilars in the breast cancer treatment landscape due later this year, there are still questions and discussions about how it will affect current and future breast cancer patients. To help understand these questions and perspectives, we decided it was important to bring together those people who are impacted the most: patients and physicians.
When you are first told you have breast cancer, your thoughts can immediately turn to your mortality and how to best save your life. You worry about how your diagnosis will affect your family, spouse or kids. More and more, the realities of the disease begin to set in and the impact it can have on your finances becomes more apparent.
World Cancer Day on February 4th gives us a chance to reflect on 2018, the work we’ve accomplished and the work that still needs to be done. This year, WCD has a brand-new message: I Am And I Will.